HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,934,520 | +17.8% | 327,898 | +4.8% | 0.04% | +21.9% |
| Q2 2023 | $32,192,050 | -21.2% | 313,000 | -16.4% | 0.03% | -22.0% |
| Q1 2023 | $40,850,339 | -1.0% | 374,293 | +3.2% | 0.04% | -6.8% |
| Q4 2022 | $41,262,286 | +124.8% | 362,586 | +22.3% | 0.04% | +120.0% |
| Q3 2022 | $18,352,000 | -24.5% | 296,518 | -2.8% | 0.02% | -20.0% |
| Q2 2022 | $24,319,000 | -43.8% | 304,924 | -25.9% | 0.02% | -32.4% |
| Q1 2022 | $43,300,000 | -1.2% | 411,559 | +1.2% | 0.04% | +60.9% |
| Q4 2021 | $43,824,000 | +1.9% | 406,681 | +3.6% | 0.02% | -4.2% |
| Q3 2021 | $43,001,000 | +18.5% | 392,551 | +1.3% | 0.02% | +26.3% |
| Q2 2021 | $36,292,000 | +64.8% | 387,559 | +62.0% | 0.02% | +72.7% |
| Q1 2021 | $22,026,000 | +19.5% | 239,297 | -5.0% | 0.01% | +22.2% |
| Q4 2020 | $18,426,000 | +34.1% | 251,886 | +42.4% | 0.01% | +12.5% |
| Q3 2020 | $13,738,000 | +11.0% | 176,842 | -20.6% | 0.01% | -11.1% |
| Q2 2020 | $12,373,000 | +28.5% | 222,605 | -31.5% | 0.01% | +12.5% |
| Q1 2020 | $9,630,000 | +45.6% | 325,103 | +78.0% | 0.01% | +60.0% |
| Q4 2019 | $6,612,000 | +64.6% | 182,649 | +23.8% | 0.01% | +66.7% |
| Q3 2019 | $4,016,000 | -33.8% | 147,478 | -41.5% | 0.00% | -40.0% |
| Q2 2019 | $6,063,000 | – | 251,936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |